Related Experiment Video
Updated: Jan 22, 2026

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential
Matthew W Boudreau1, Jessie Peh1, Paul J Hergenrother1
1Department of Chemistry and Institute for Genomic Biology , University of Illinois at Urbana-Champaign , Urbana , Illinois , United States.
Abstract:
Many anticancer strategies rely on the promotion of apoptosis in cancer cells as a means to shrink tumors. Crucial for apoptotic function are executioner caspases, most notably caspase-3, that proteolyze a variety of proteins, inducing cell death. Paradoxically, overexpression of procaspase-3 (PC-3), the low-activity zymogen precursor to caspase-3, has been reported in a variety of cancer types. Until recently, this counterintuitive overexpression of a pro-apoptotic protein in cancer has been puzzling. Recent studies suggest subapoptotic caspase-3 activity may promote oncogenic transformation, a possible explanation for the enigmatic overexpression of PC-3. Herein, the overexpression of PC-3 in cancer and its mechanistic basis is reviewed; collectively, the data suggest the potential for exploitation of PC-3 overexpression with PC-3 activators as a targeted anticancer strategy.
Insights
Overexpression of procaspase-3 (PC-3) in cancer, a pro-apoptotic protein, is puzzling. Recent findings suggest PC-3 activators could be a novel targeted anticancer strategy by exploiting this overexpression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Anticancer strategies often target apoptosis, a programmed cell death process.
- Executioner caspases, like caspase-3, are key mediators of apoptosis.
- Paradoxical overexpression of procaspase-3 (PC-3) in various cancers has been observed.
Purpose of the Study:
- To review the overexpression of PC-3 in cancer.
- To explore the mechanistic basis for PC-3 overexpression.
- To evaluate PC-3 activators as a potential targeted anticancer strategy.
Main Methods:
- Literature review of studies on PC-3 in cancer.
- Analysis of mechanistic insights into PC-3 overexpression.
- Synthesis of data suggesting therapeutic potential.
Main Results:
- Subapoptotic caspase-3 activity may promote oncogenic transformation.
- This activity offers a potential explanation for PC-3 overexpression in cancer.
- PC-3 overexpression presents a targetable vulnerability in cancer cells.
Conclusions:
- PC-3 overexpression in cancer is a significant finding with mechanistic underpinnings.
- Targeting PC-3 with specific activators represents a promising novel anticancer therapeutic avenue.
- Exploiting PC-3 overexpression could lead to more effective, targeted cancer treatments.
More Related Videos
Related Concept Videos
Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
Naturalistic Observations
Therapeutic Index
Actor-Observer Effect
Observational Learning
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...

